Jordan R. Barrett

Scripps Research Institute — United States

Medicine · Health Sciences

20h-index11.2kcitations59works7.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Malaria Research and Control(33), Complement system in diseases(17), Mosquito-borne diseases and control(16), vaccines and immunoinformatics approaches(13), SARS-CoV-2 and COVID-19 Research(12)

Publications57 total

Structural basis for synergistic antibody protection against the essential malaria invasion complex protein RIPR
2025
Synergistic non-neutralizing plasma antibodies to PfRH5 drive potent malaria parasite growth inhibition
2025Open Access
B and T cell responses to pre-erythrocytic R21/Matrix-M and blood-stage RH5.1/Matrix-M malaria vaccines in endemic settings
2025Open Access
Development of clinical immunity to Plasmodium vivax following repeat controlled human malaria infection
Nature Communications·2025· 2 citedOpen Access
Age differences in immunity to human seasonal coronaviruses and the immunogenicity of ChAdOx1 nCoV-19 (AZD1222)
EBioMedicine·2025Open Access
Diagnosis of <i>Plasmodium falciparum</i> malaria at very low parasitaemias using a commercially available LAMP assay and RDT
Transactions of the Royal Society of Tropical Medicine and Hygiene·2025· 2 citedOpen Access
<i>Plasmodium falciparum</i> infection induces T cell tolerance that is associated with decreased disease severity upon re-infection
The Journal of Experimental Medicine·2025· 3 citedOpen Access
An experimental model of clinical immunity for human malaria
2025· 1 citedOpen Access
Synergistic blockade of TIGIT and PD-L1 increases type-1 inflammation and improves parasite control during murine blood-stage <i>Plasmodium yoelii</i> non-lethal infection
Infection and Immunity·2024· 1 citedOpen Access
Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotype
Cell·2024· 24 citedOpen Access
Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5
Cell·2024· 13 citedOpen Access
Preclinical development of a stabilized RH5 virus-like particle vaccine that induces improved antimalarial antibodies
Cell Reports Medicine·2024· 19 citedOpen Access
Blood-stage malaria vaccine candidate RH5.1/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trial
The Lancet Infectious Diseases·2024· 35 citedOpen Access
Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex
Nature Communications·2024· 27 citedOpen Access
Has the <scp>COVID</scp> ‐19 pandemic resulted in more advanced breast cancer? A hospital‐based retrospective study
ANZ Journal of Surgery·2024· 4 citedOpen Access
First Phase 1b, single-center, age de-escalation trial of the <i>P. falciparum</i> blood-stage malaria vaccine candidate RH5.1/Matrix-M <sup>™</sup> : a delayed boost regimen induces high levels of functional antibodies in 5-17 month old Tanzanian infants
2024Open Access
Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex
2024· 1 citedOpen Access
Analyses of human vaccine-specific circulating and bone marrow-resident B cell populations reveal benefit of delayed vaccine booster dosing with blood-stage malaria antigens
Frontiers in Immunology·2024· 8 citedOpen Access
PvDBPII elicits multiple antibody-mediated mechanisms that reduce growth in a Plasmodium vivax challenge trial
npj Vaccines·2024· 6 citedOpen Access
Preclinical Development of a Stabilized RH5 Virus-Like Particle Vaccine that Induces Improved Anti-Malarial Antibodies
2024· 7 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Simon J. Draper(38), Angela M. Minassian(37), Sarah E. Silk(35), Carolyn M. Nielsen(21), Kazutoyo Miura(19), Carole A. Long(19), Nick J. Edwards(17), Lloyd D. W. King(16), Jee-Sun Cho(15), Ababacar Diouf(15), Alison M. Lawrie(14), Fay L. Nugent(14), Yrene Themistocleous(14), Mimi M. Hou(13), Amelia M. Lias(13), Kirsty McHugh(12), Megan Baker(11), Ian Poulton(11), Doris Quinkert(11), Alexander D. Douglas(10)